Keywords: Adenovirus vector–based vaccine; DNA plasmid vaccine; Zika virus; chimeric vaccine; clinical trial; flavivirus; live attenuated vaccine; nucleoside-modified mRNA vaccine; purified inactivated virus vaccine; vaccine.